Home > > > > Report Detail

Poliomyelitis Vaccine - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 95
Inquire Before Buying

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

The global Poliomyelitis Vaccine market size is expected to reach US$ 835.1 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Poliomyelitis Vaccine in various end use industries. The expanding demands from the VAPP and VDPV, are propelling Poliomyelitis Vaccine market. Poliomyelitis Vaccine ?, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Poliomyelitis Vaccine ? segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Poliomyelitis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Poliomyelitis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Poliomyelitis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliomyelitis Vaccine sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Poliomyelitis Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group and Eli Lilly, etc.

The global Poliomyelitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- GSK

- Sanofi-Pasteur

- Merck

- Crucell

- China National Biotech Group

- Eli Lilly

Global Poliomyelitis Vaccine market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Poliomyelitis Vaccine market, Segment by Type:

- Poliomyelitis Vaccine ?

- Poliomyelitis Vaccine ?

- Poliomyelitis Vaccine ?

- Oral Poliomyelitis Vaccine

Global Poliomyelitis Vaccine market, by Application

- VAPP

- VDPV

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Poliomyelitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Poliomyelitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Poliomyelitis Vaccine - Global Market Insights and Sales Trends 2024

Table of Contents
1 Poliomyelitis Vaccine Market Overview
1.1 Poliomyelitis Vaccine Product Overview
1.2 Poliomyelitis Vaccine Market Segment by Type
1.2.1 Poliomyelitis Vaccine ?
1.2.2 Poliomyelitis Vaccine ?
1.2.3 Poliomyelitis Vaccine ?
1.2.4 Oral Poliomyelitis Vaccine
1.3 Global Poliomyelitis Vaccine Market Size by Type
1.3.1 Global Poliomyelitis Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Poliomyelitis Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
2 Global Poliomyelitis Vaccine Market Competition by Company
2.1 Global Top Players by Poliomyelitis Vaccine Sales (2018-2023)
2.2 Global Top Players by Poliomyelitis Vaccine Revenue (2018-2023)
2.3 Global Top Players by Poliomyelitis Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Poliomyelitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poliomyelitis Vaccine Market Competitive Situation and Trends
2.5.1 Poliomyelitis Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Poliomyelitis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Poliomyelitis Vaccine Market
2.8 Key Manufacturers Poliomyelitis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poliomyelitis Vaccine Status and Outlook by Region
3.1 Global Poliomyelitis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Poliomyelitis Vaccine Historic Market Size by Region
3.2.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Poliomyelitis Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Poliomyelitis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Region
3.3.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Poliomyelitis Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Poliomyelitis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Poliomyelitis Vaccine by Application
4.1 Poliomyelitis Vaccine Market Segment by Application
4.1.1 VAPP
4.1.2 VDPV
4.2 Global Poliomyelitis Vaccine Market Size by Application
4.2.1 Global Poliomyelitis Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Poliomyelitis Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Poliomyelitis Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
5 North America Poliomyelitis Vaccine by Country
5.1 North America Poliomyelitis Vaccine Historic Market Size by Country
5.1.1 North America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
5.2 North America Poliomyelitis Vaccine Forecasted Market Size by Country
5.2.1 North America Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
6 Europe Poliomyelitis Vaccine by Country
6.1 Europe Poliomyelitis Vaccine Historic Market Size by Country
6.1.1 Europe Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Poliomyelitis Vaccine Forecasted Market Size by Country
6.2.1 Europe Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Poliomyelitis Vaccine by Region
7.1 Asia-Pacific Poliomyelitis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Poliomyelitis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2024-2029)
8 Latin America Poliomyelitis Vaccine by Country
8.1 Latin America Poliomyelitis Vaccine Historic Market Size by Country
8.1.1 Latin America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Poliomyelitis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Poliomyelitis Vaccine by Country
9.1 Middle East and Africa Poliomyelitis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Poliomyelitis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Poliomyelitis Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Poliomyelitis Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Crucell
10.4.1 Crucell Company Information
10.4.2 Crucell Introduction and Business Overview
10.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Crucell Poliomyelitis Vaccine Products Offered
10.4.5 Crucell Recent Development
10.5 China National Biotech Group
10.5.1 China National Biotech Group Company Information
10.5.2 China National Biotech Group Introduction and Business Overview
10.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 China National Biotech Group Poliomyelitis Vaccine Products Offered
10.5.5 China National Biotech Group Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Eli Lilly Poliomyelitis Vaccine Products Offered
10.6.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poliomyelitis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poliomyelitis Vaccine Industrial Chain Analysis
11.4 Poliomyelitis Vaccine Market Dynamics
11.4.1 Poliomyelitis Vaccine Industry Trends
11.4.2 Poliomyelitis Vaccine Market Drivers
11.4.3 Poliomyelitis Vaccine Market Challenges
11.4.4 Poliomyelitis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poliomyelitis Vaccine Distributors
12.3 Poliomyelitis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Poliomyelitis Vaccine ?
Table 2. Major Company of Poliomyelitis Vaccine ?
Table 3. Major Company of Poliomyelitis Vaccine ?
Table 4. Major Company of Oral Poliomyelitis Vaccine
Table 5. Global Poliomyelitis Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 7. Global Poliomyelitis Vaccine Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Poliomyelitis Vaccine Sales by Type (2018-2023) & (US& Million)
Table 9. Global Poliomyelitis Vaccine Market Share in Value by Type (2018-2023)
Table 10. Global Poliomyelitis Vaccine Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Poliomyelitis Vaccine Sales by Type (2024-2029) & (K Units)
Table 12. Global Poliomyelitis Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Poliomyelitis Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Poliomyelitis Vaccine Sales Market Share in Value by Type (2024-2029)
Table 15. Global Poliomyelitis Vaccine Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Poliomyelitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 17. North America Poliomyelitis Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Poliomyelitis Vaccine Sales (K Units) by Type (2018-2023)
Table 19. Europe Poliomyelitis Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Poliomyelitis Vaccine Sales (K Units) by Type (2018-2023)
Table 21. Asia-Pacific Poliomyelitis Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Poliomyelitis Vaccine Sales (K Units) by Type (2018-2023)
Table 23. Latin America Poliomyelitis Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Poliomyelitis Vaccine Sales (K Units) by Type (2018-2023)
Table 25. Middle East and Africa Poliomyelitis Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Poliomyelitis Vaccine Sales by Company (2018-2023) & (K Units)
Table 27. Global Poliomyelitis Vaccine Sales Share by Company (2018-2023)
Table 28. Global Poliomyelitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Poliomyelitis Vaccine Revenue Share by Company (2018-2023)
Table 30. Global Market Poliomyelitis Vaccine Price by Company (2018-2023) & (USD/Unit)
Table 31. Global Poliomyelitis Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Poliomyelitis Vaccine Market
Table 35. Key Manufacturers Poliomyelitis Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Poliomyelitis Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Poliomyelitis Vaccine Sales by Region (2018-2023) & (K Units)
Table 39. Global Poliomyelitis Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Poliomyelitis Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Poliomyelitis Vaccine Sales Market Share in Value by Region (2018-2023)
Table 42. Global Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 43. Global Poliomyelitis Vaccine Sales by Region (2024-2029) & (K Units)
Table 44. Global Poliomyelitis Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Poliomyelitis Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Poliomyelitis Vaccine Sales Market Share in Value by Region (2024-2029)
Table 47. Global Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Poliomyelitis Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Poliomyelitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 50. Global Poliomyelitis Vaccine Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Poliomyelitis Vaccine Sales Market Share in Value by Application (2018-2023)
Table 53. Global Poliomyelitis Vaccine Price by Application (2018-2023) & (USD/Unit)
Table 54. Global Poliomyelitis Vaccine Sales by Application (2024-2029) & (K Units)
Table 55. Global Poliomyelitis Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Poliomyelitis Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Poliomyelitis Vaccine Sales Market Share in Value by Application (2024-2029)
Table 58. Global Poliomyelitis Vaccine Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Poliomyelitis Vaccine Sales by Application (2018-2023) (K Units)
Table 60. North America Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Poliomyelitis Vaccine Sales by Application (2018-2023) (K Units)
Table 62. Europe Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Poliomyelitis Vaccine Sales by Application (2018-2023) (K Units)
Table 64. Asia-Pacific Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Poliomyelitis Vaccine Sales by Application (2018-2023) (K Units)
Table 66. Latin America Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Poliomyelitis Vaccine Sales by Application (2018-2023) (K Units)
Table 68. Middle East and Africa Poliomyelitis Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 70. North America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Poliomyelitis Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2023)
Table 73. North America Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 74. North America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Poliomyelitis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 78. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Poliomyelitis Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 82. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Poliomyelitis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 94. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Poliomyelitis Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Poliomyelitis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2029)
Table 109. GSK Company Information
Table 110. GSK Introduction and Business Overview
Table 111. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. GSK Poliomyelitis Vaccine Product
Table 113. GSK Recent Development
Table 114. Sanofi-Pasteur Company Information
Table 115. Sanofi-Pasteur Introduction and Business Overview
Table 116. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Sanofi-Pasteur Poliomyelitis Vaccine Product
Table 118. Sanofi-Pasteur Recent Development
Table 119. Merck Company Information
Table 120. Merck Introduction and Business Overview
Table 121. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Merck Poliomyelitis Vaccine Product
Table 123. Merck Recent Development
Table 124. Crucell Company Information
Table 125. Crucell Introduction and Business Overview
Table 126. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Crucell Poliomyelitis Vaccine Product
Table 128. Crucell Recent Development
Table 129. China National Biotech Group Company Information
Table 130. China National Biotech Group Introduction and Business Overview
Table 131. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. China National Biotech Group Poliomyelitis Vaccine Product
Table 133. China National Biotech Group Recent Development
Table 134. Eli Lilly Company Information
Table 135. Eli Lilly Introduction and Business Overview
Table 136. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Eli Lilly Poliomyelitis Vaccine Product
Table 138. Eli Lilly Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Poliomyelitis Vaccine Market Trends
Table 142. Poliomyelitis Vaccine Market Drivers
Table 143. Poliomyelitis Vaccine Market Challenges
Table 144. Poliomyelitis Vaccine Market Restraints
Table 145. Poliomyelitis Vaccine Distributors List
Table 146. Poliomyelitis Vaccine Downstream Customers
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Poliomyelitis Vaccine Product Picture
Figure 2. Global Poliomyelitis Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Poliomyelitis Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Poliomyelitis Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Poliomyelitis Vaccine ?
Figure 6. Global Poliomyelitis Vaccine ? Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Poliomyelitis Vaccine ?
Figure 8. Global Poliomyelitis Vaccine ? Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Poliomyelitis Vaccine ?
Figure 10. Global Poliomyelitis Vaccine ? Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Oral Poliomyelitis Vaccine
Figure 12. Global Oral Poliomyelitis Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Poliomyelitis Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Poliomyelitis Vaccine Sales Market Share by Type in 2022 & 2029
Figure 15. North America Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliomyelitis Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliomyelitis Vaccine Revenue in 2022
Figure 27. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of VAPP
Figure 29. Global VAPP Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of VDPV
Figure 31. Global VDPV Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Poliomyelitis Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Poliomyelitis Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Poliomyelitis Vaccine Manufacturing Cost Structure
Figure 45. Poliomyelitis Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs